1. Microbiota, Inflammation, and Gut Barrier Dysfunction in HCC
   Amit Kumar Ram et al, 2021, Liver Pathology CrossRef
2. Cervical Cancer Imaging Features Associated With ADRB1 as a Risk Factor for Cerebral Neurovascular Metastases
   Xingju Zheng et al, 2022, Frontiers in Neurology CrossRef
3. Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
   Y. Linda Wu et al, 2023, Frontiers in Oncology CrossRef
4. Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis
   Xinyi He et al, 2023, Frontiers in Pharmacology CrossRef
5. Development, characterization, and in vitro evaluation of adhesive fibrous mat for mucosal propranolol delivery
   Graciela Lizeth Pérez-González et al, 2021, e-Polymers CrossRef
6. VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
   A. V. Savinkova et al, 2018, Siberian journal of oncology CrossRef
7. β2-Adrenergic Receptor Signaling Pathway Stimulates the Migration and Invasion of Cancer Cells via Src Activation
   Jae-Hoon Jeong et al, 2022, Molecules CrossRef
8. Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
   He-Yun Cheng et al, 2022, Frontiers in Pharmacology CrossRef
9. Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-Analysis
   Tzu-Hao Li et al, 2020, Gastroenterology Research and Practice CrossRef
10. Trial watch: beta-blockers in cancer therapy
    Killian Carnet Le Provost et al, 2023, OncoImmunology CrossRef
11. Perioperative use of β-blockers in oncological patients
    P. P. Sorochan et al, 2021, Український радіологічний та онкологічний журнал CrossRef
12. Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
    L. E. Anselmino et al, 2023, Scientific Reports CrossRef
13. Anticancer effect of propranolol on diethylnitrosamine‐induced hepatocellular carcinoma rat model
    Yomna M. Tamim et al, 2024, Fundamental & Clinical Pharmacology CrossRef
14. Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer
    Madeleine B. Hopson et al, 2021, Breast Cancer Research and Treatment CrossRef
15. Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation
    Sachin G Nair et al, 2024, Clinical & Experimental Metastasis CrossRef
16. Developing a machine learning model to identify protein–protein interaction hotspots to facilitate drug discovery
    Rohit Nandakumar et al, 2020, PeerJ CrossRef
17. Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System
    Imogen M. Roth et al, 2019, Frontiers in Oncology CrossRef